The Prognostic Model Established by the Differential Expression Genes Based on CD8<sup>+</sup> T Cells to Evaluate the Prognosis and the Response to Immunotherapy in Osteosarcoma

<div>Pathway enrichment analysis of high- and low-risk scores in CD8-DEG model. (a) GO analysis of CD8-DEGs model. (b) KEGG analysis of CD8-DEG model.</div>

Mediators of Inflammation

fig5

Figure 5

Figure 5: The Prognostic Model Established by the Differential Expression Genes Based on CD8<sup>+</sup> T Cells to Evaluate the Prognosis and the Response to Immunotherapy in Osteosarcoma 

Figure 5 | The Prognostic Model Established by the Differential Expression Genes Based on CD8+ T Cells to Evaluate the Prognosis and the Response to Immunotherapy in Osteosarcoma 